A Comparison of the Prognosis of SARS-CoV-2 Viral Infection in Patients with and Without Underlying Heart Disease
International Journal of Cardiovascular Practice · 2022
DOI: 10.5812/intjcardiovascpract-132258 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cardiovascular Practice, 2022. Verfasst von Hamid Khederlou und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Since December 2019, a pneumonia outbreak has spread through a viral infection. Originally, the virus pathogen was termed SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). SARS-CoV-2 can cause severe and life-threatening problems.
Objectives
The purpose of this study was to describe the prognostic comparison of SARS-CoV-2 viral infection in patients with and without underlying heart disease in our center.
Methods
A total of 400 Iranian adult patients with COVID-19 enrolled in this descriptive-analytical research. The study population was categorized into 4 groups: (1) no underlying disorder, (2) only cardiovascular complication, (3) only non-cardiovascular disease (CVD), and (4) cardiovascular and non-cardiovascular complications. The prognosis was adjudicated based on underlying diseases. Anthropometric details were also gathered. Finally, the data were analyzed using SPSS version 25.
Results
The mortality rate was almost 4.17 times more in patients suffering from both cardiovascular and non-cardiovascular complications compared with the first group having no underlying disorders. This rate was 3.98 times more than the baseline in patients complicated with CVD alone. Based on a logistic regression model, COVID-19 prognosis was associated with age, underlying disorder type, length of hospitalization, the requirement for the intensive care unit (ICU), length of stay in ICU, the need for intubation, reservoir bag-mask requirement, and some of the life-threatening complications such as pneumonia and sepsis.
Conclusions
Cardiovascular underlying disorders (such as myocarditis and deep vein thrombosis) are likely to be linked to the prognosis of COVID-19.
Zitieren
APA
Khederlou, H., Ebrahimi, V., Rasouli, A., & Mehrpooya, M. (2022). A Comparison of the Prognosis of SARS-CoV-2 Viral Infection in Patients with and Without Underlying Heart Disease. International Journal of Cardiovascular Practice. https://doi.org/10.5812/intjcardiovascpract-132258
Vancouver
Khederlou H, Ebrahimi V, Rasouli A, Mehrpooya M. A Comparison of the Prognosis of SARS-CoV-2 Viral Infection in Patients with and Without Underlying Heart Disease. International Journal of Cardiovascular Practice. 2022. doi:10.5812/intjcardiovascpract-132258
BibTeX
@article{Khederlou2022,
author = {Khederlou, Hamid and Ebrahimi, Vida and Rasouli, Ahmadreza and Mehrpooya, Maryam},
title = {A Comparison of the Prognosis of SARS-CoV-2 Viral Infection in Patients with and Without Underlying Heart Disease},
journal = {International Journal of Cardiovascular Practice},
year = {2022},
doi = {10.5812/intjcardiovascpract-132258}
}
EUVIMED